Found 598 results
2023
Kaleem S, Zhang C, Gusdon AM, Oh S, Merkler AE, Avadhani R, Awad I, Hanley DF, Kamel H, Ziai WC et al..  2023.  Association Between Neutrophil-Lymphocyte Ratio and 30-Day Infection and Thrombotic Outcomes After Intraventricular Hemorrhage: A CLEAR III Analysis.. Neurocrit Care.
Witsch J, Roh D, Oh S, Iadecola C, Diaz-Arrastia R, Kasner SE, Mayer SA, Murthy SB.  2023.  Association Between Soluble Intercellular Adhesion Molecule-1 and Intracerebral Hemorrhage Outcomes in the FAST Trial.. Stroke.
Zhou L, Li Y, Sweeney EM, Wang XH, Kuceyeski A, Chiang GC, Ivanidze J, Wang Y, Gauthier SA, de Leon MJ et al..  2023.  Association of brain tissue cerebrospinal fluid fraction with age in healthy cognitively normal adults.. Front Aging Neurosci. 15:1162001.
Zolin A, Zhang C, Ooi H, Sarva H, Kamel H, Parikh NS.  2023.  Association of liver fibrosis with cognitive decline in Parkinson's disease.. J Clin Neurosci. 119:10-16.
Wechsler PM, Navi BB.  2023.  Bypassing Closest Stroke Center for Intracerebral Hemorrhage-Not So Fast!. JAMA Neurol.
Garton ALA, Oh SE, Müller A, Avadhani R, Zhang C, Merkler AE, Awad I, Hanley D, Kamel H, Ziai WC et al..  2023.  Catheter Tract Hemorrhages and Intracerebral Hemorrhage Outcomes in the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Trial.. Neurosurgery.
Wechsler PM, Liberman AL, Restifo D, Abramson EL, Navi BB, Kamel H, Parikh NS.  2023.  Cost-Effectiveness of Smoking Cessation Interventions in Patients With Ischemic Stroke and Transient Ischemic Attack.. Stroke.
Williams MJ, Okai AF, Cross AH, Monson NL, Vartanian T, Thrower BW, Reder AT, English JB, Wu GF, Bernitsas E et al..  2023.  Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.. Mult Scler Relat Disord. 76:104794.
Zelikovich AS, Safdieh JE, Robbins MS.  2023.  The Development and Utilization of a Virtual Twitter Onboarding Curriculum for Neurologists, Trainees, and Students: A Prospective Study. Neurology Education. 2(3)
Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen H-C, Carruthers R et al..  2023.  Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.. Proc Natl Acad Sci U S A. 120(3):e2207291120.
Michaelson NMiriam, Watsula A, Bakare-Okpala A, Mohamadpour M, Chukwueke UN, Budhu JA.  2023.  Disparities in Neuro-Oncology.. Curr Neurol Neurosci Rep.
Zolin A, Broner SW, Yoo A, Guan I, Lakhani S, Trabilsy M, Klebanoff L, Vo M, Sarva H.  2023.  Dystonia phenomenology and treatment response in migraine.. Headache. 63(2):255-263.
Dominguez M, Minen M, Robbins MS.  2023.  Educational initiatives in headache medicine: A 20-year scoping review.. Headache.
Shetty SV, Mazzucco MR, Winokur P, Haigh SV, Rumah KRashid, Fischetti VA, Vartanian T, Linden JR.  2023.   Epsilon Toxin Binds to and Kills Primary Human Lymphocytes.. Toxins (Basel). 15(7)
Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al..  2023.  Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)
Homssi M, Sweeney EM, Demmon E, Mannheim W, Sakirsky M, Wang Y, Gauthier SA, Gupta A, Nguyen TD.  2023.  Evaluation of the Statistical Detection of Change Algorithm for Screening Patients with MS with New Lesion Activity on Longitudinal Brain MRI.. AJNR Am J Neuroradiol. 44(6):649-655.
Witsch J, Rutrick SB, Lansdale KN, Seitz A, Kamel H, Parikh NS, Segal AZ, Mir SA, Murthy SB, Niogi SN et al..  2023.  Influenza-Like Illness as a Short-Term Risk Factor for Arterial Dissection.. Stroke.
Tozlu C, Card S, Jamison K, Gauthier SA, Kuceyeski A.  2023.  Larger lesion volume in people with multiple sclerosis is associated with increased transition energies between brain states and decreased entropy of brain activity.. Netw Neurosci. 7(2):539-556.
Perumal J, Balabanov R, Balcer L, Galetta S, Sun Z, Li H, Rutledge D, Avila RL, Fox RJ.  2023.  Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analysis.. Neurol Ther. 12(3):833-848.